Product Information
DAYVIGO 5 MG TABLET is a brand product labeled by Eisai Inc., priced at $11.5839 per EA under NDC 62856040530. Its NADAC has been published 301 times since Sep 23, 2020.
Strength
5 mg/1
Manufacturer
Eisai Inc.NDC
62856040530
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEMBOREXANTApproval Type
New Drug (NDA)
FDA Application
NDA212028On Market Since
4/7/2020
Pharmacological Classes
Price Statistics
The NADAC for DAYVIGO 5 MG TABLET has been published 301 times since Sep 23, 2020, and over the history we have for it it has risen 31.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.5839 per EA |
|---|---|
| All-time high | $11.5839 (Jun 24, 2026) |
| All-time low | $8.7826 (Sep 23, 2020) |
| 52-week high | $11.5839 |
| 52-week low | $11.2308 |
| Median price | $10.1639 |
| Average price | $10.2067 |
| Largest weekly change | +8.2% (Jan 25, 2023) |
| Weeks tracked | 301 |
| Tracking since | Sep 23, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lemborexant market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DAYVIGO 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DAYVIGO 5 MG TABLET, manufactured by Eisai Inc., is $11.5839 per EA (NDC 62856040530), effective Jun 24, 2026.
How has the price of DAYVIGO 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for DAYVIGO 5 MG TABLET has risen 31.9%. It has been tracked across 301 weekly CMS publications since Sep 23, 2020.
What are the highest and lowest recorded NADAC prices for DAYVIGO 5 MG TABLET?
Since Sep 23, 2020, the NADAC for DAYVIGO 5 MG TABLET has ranged from a low of $8.7826 (Sep 23, 2020) to a high of $11.5839 (Jun 24, 2026), with a median of $10.1639 per EA.
Are there cheaper alternatives to DAYVIGO 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DAYVIGO 5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures DAYVIGO 5 MG TABLET?
DAYVIGO 5 MG TABLET (NDC 62856040530) is labeled by Eisai Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification